The Evolving ACC-NCDR Programs: What you need to know for your practice

Size: px
Start display at page:

Download "The Evolving ACC-NCDR Programs: What you need to know for your practice"

Transcription

1 The Evolving ACC-NCDR Programs: What you need to know for your practice John S. Rumsfeld, MD PhD FACC Chief Science Officer and Chair, American College of Cardiology National Cardiovascular Data Registry (NCDR) Programs National Director of Cardiology, US Veterans Health Administration Professor of Medicine, University of Colorado School of Medicine Science tells us what we can do; Guidelines tell us what we should do; Registries tell us what we re actually doing. ~Lukas Kappenberger, MD 1

2 Practice Research Technology Mission To improve the quality of cardiovascular patient care by providing information, knowledge and tools; implementing quality initiatives; and supporting research that improves patient care and outcomes. 2

3 9 national programs > 2000 hospitals > 2500 cardiologists 40 million clinical records 2 additional programs LAAO and AFAR in 2015/16 NCDR Data Quality Program The overall accuracy of data abstraction for the CathPCI, ICD, and ACTION-GWTG registries were, respectively, 93.1%, 91.2%, and 90.0%. Messenger JC et al. J Am Coll Cardiol 2012 Oct 16;60(16):

4 NCDR Collaborations NCDR: Not Just Data Standard data elements and definitions Clinical Data Database Quality Assessment Quality Improvement Clinical Research Meaningful Role in Clinical Practice / U.S. Healthcare Reform Bufalino VJ, Masoudi FA, et al. Circulation. 2011;123:

5 QCDR and MACRA 5

6 NCDR: Quality Feedback & Benchmarking Evidence to Practice (E2P) Evidence / Guidelines Practice Implications Practice Improvement NCDR Rapid Registry Response NCDR Evidence in Action 6

7 Maddox TM et al. J Am Coll Cardiol May 26, 2015; vol 65; pp Evidence In Action (EIA) Track ACC guidelines / documents: pre-publication assessment and planning Tailored alert to NCDR practices / hospitals: Show their current practice Highlight key guideline change Link to ACC resources Track performance; Share best practices Update data fields and quality metrics 7

8 Dashboards Site, Physician, Corporate, C-suite /CV Director Key Metrics ACTION Registry CathPCI Registry ACTION: Overall AMI Performance Composite CathPCI: PCI In-hospital Risk Adjusted Mortality (All Patients) ICD: Incidence of Death or Major Adverse Event (Implant Procedures) Site Admissions STEMI: 90 NSTEMI: 39 Procedure Volumes Diagnostic Cath: PCI: Registry Metric Type Measure Value Percentile Change Performance ACTION CathPCI AUC CathPCI AUC CathPCI AUC CathPCI Performance Measures Performance Measures Time from ED arrival at STEMI referral facility to Primary PCI at STEMI receiving facility among transferred patients Patients with Acute Coronary Syndrome: Proportion of evaluated PCI procedures that were inappropriate Patients without Acute Coronary Syndrome: Proportion of evaluated PCI procedures that were inappropriate Proportion of PCI procedures not classifiable for AUC reporting Composite: Discharge medications in eligible PCI patients 98 75% 0 0% 90% % % 90% +5 99% 90% 0 8

9 Clinical registries provide knowledge about clinical effectiveness Basic biomedical science Clinical efficacy knowledge Clinical effectiveness knowledge Improved health care quality and value and population health NIH Roadmap: JAMA 2008;299: ; T1-T4 Research: Nature Medicine 2012;18:35 41 Role of Clinical Registries: Rumsfeld JS et al. U.S. Cardiology 2009;11-15 NCDR Publications 9

10 U.S. Institute of Medicine domains of high quality healthcare Effective Efficient Equitable Safe Timely Patient- Centered Institute of Medicine. Crossing the Quality Chasm: A New Healthcare System for the 21 st Century. National Academy Press 2001 Effective + Safe Care 10

11 Do clinical trial benefits extend to clinical practice? Compare real-world outcomes after ICD implantation with MADIT-II and SCD-HeFT Trials 5,816 propensity matched patients from ICD Registry from Median follow up: 35 months Al-Khatib S et al. JAMA. 2013;309:55-62 Similar outcomes between trials and practice. Al-Khatib S et al, JAMA. 2013;309(1):

12 A similar effectiveness story for TAVR in the U.S. Mack MJ et al. JAMA 2013;310: Comparative effectiveness and safety 829 hospitals; 22,778 dialysis patients; 22.3% received a contraindicated antithrombotic Tsai TT et al. JAMA 2009;302:

13 Acute MI registry data highlight major bleeding complication rates Mortality Bleeding Roe M et al. J Am Coll Cardiol 2010; Vol. 56, No. 4: Anticoagulant medication overdosing is a problem * Infusion (> 15 units/kg/hr) or bolus (> 70 units/kg) # Initial dose (> 1.05 mg/kg) or total 24 hr dose (> 10 mg over recommended) NCDR ACTION Registry-GWTG Data: July 1, 2009 June 30, 2010 Alexander KP, et. al. JAMA 2005;294(24):

14 Medication dosing is now a quality metric in hospital feedback reports Masoudi FA et al. Cardiovascular Care Facts: A Report from the NCDR: 2011 J Am Coll Cardiol 2013;62: Device safety: post-market studies and surveillance VasoSeal withdrawn from U.S. market VasoSeal had higher risk of vascular complications compared with manual compression (OR=2.38, p=0.0004) Tavris DR et al. J Invasive Cardiol. 2005;17:

15 Efficient Care Can PCI patients be discharged on the same day as the procedure? 107,018 patients 65 y/o undergoing elective PCI procedures at 903 hospitals Rao SV et al. JAMA. 2011;306(13):

16 Patients can be safely discharged, thus improving efficiency of care Complications rare 2 day and 30 day complication rates similar between groups Rao SV et al.jama. 2011;306(13): Rao SV et al. JAMA. 2011;306(13):

17 500,154 PCIs from 1091 hospitals Overall 4.1% inappropriate PCI rate Among non-acute PCIs:11.6% inappropriate Chan PS et al. JAMA 2011;306:53-61 Hospital variation in inappropriate non-acute PCIs Chan PS et al. JAMA 2011;306:

18 Timely Care Door to balloon times were slow and unchanging in the U.S. 18

19 Six strategies were identified among the best performing hospitals Bradley EH et al. N Engl J Med Nov 30;355(22): The ACC launched a national quality initiative 19

20 There were significant increases in D2B strategies used by hospitals Bradley EH et al. J Am Coll Cariol 2009; 54 (25): There was a significant improvement in D2B times nationally > 75% of patients with STEMI had D2B times within 90 min by Bradley EH et al. J Am Coll Cariol 2009; 54 (25):

21 Menees D. et al. NEJM 2013;369: Menees D. et al. NEJM 2013;369:

22 55% increase in the number of patients undergoing primary PCI (expanded indications) Secular trend toward more complex cases, changing case-mix. Within each year, shorter D2B times associated with significantly lower mortality Nallamothu BK et al. Lancet 2014 Nov 19. doi: /S (14) [Epub ahead of print] SCAAR: Swedish Coronary Angiography And Angioplasty Registry 22

23 Registry clinical trial infrastructure Baseline data Site recruitment Clinical Registry Program Clinical trial Post-trial surveillance The evolution of research using clinical registries Basic biomedical science Clinical efficacy knowledge Clinical effectiveness knowledge Improved health care quality and value and population health JAMA 2008;299: and Nature Medicine 2012;18:

24 The 21st Century Cures Act Pre-Market Post-Market Evolving Role for NCDR Programs Phase 1 Phase 2 Phase 3 Phase 4 Post- Post- Approval Market Studies Surveillance Clinical Registries Clinical Trials Clinical Practice 24

25 Post-Approval Studies (PAS) Edwards Post Approval Studies TVT Registry Abbott Post Approval Studies TVT Registry Boston Scientific Post Approval Study ICD Registry Medtronic Post Approval Study TVT Registry Boston Scientific Post Approval Study LAAO Registry Practice Research Technology 25

26 At 3pm Friday, local autocrat C. Montgomery Burns was shot following a tense confrontation at Town Hall. Burns was rushed to a nearby hospital where he was pronounced dead. He was then transferred to a better hospital where doctors upgraded his condition to alive. --Kent Brockman Newscaster, The Simpsons Thank you John.Rumsfeld@ucdenver.edu 26

The NCDR and Clinical Practice Guideline Development

The NCDR and Clinical Practice Guideline Development The NCDR and Clinical Practice Guideline Development Gregory J. Dehmer, MD, FACC, FACP, FSCAI Professor of Medicine Texas A&M HSC College of Medicine Director, Cardiology Division Baylor Scott & White

More information

National Cardiovascular Data Registry

National Cardiovascular Data Registry National Cardiovascular Data Registry Young and Early Career Investigators ACC/AGS/NIA Multimorbidity in Older Adults with Cardiovascular Disease Workshop Ralph Brindis, MD MPH Senior Medical Officer,

More information

ACTION Registry GWTG Research and Publications Update

ACTION Registry GWTG Research and Publications Update ACTION Registry GWTG Research and Publications Update Dr. Michael Kontos Director, Coronary Intensive Care Unit Pauley Heart Center, Virginia Commonwealth University The following relationships exist:

More information

Transfer in D2B. Scott D Friedman, MD FACC Medical Director, Cardiology Services Shore Health System of Maryland. The Problem

Transfer in D2B. Scott D Friedman, MD FACC Medical Director, Cardiology Services Shore Health System of Maryland. The Problem Transfer in D2B Scott D Friedman, MD FACC Medical Director, Cardiology Services Shore Health System of Maryland The Problem NRMI-5: North Carolina, July 2003- June 2004 NC Nation Guidelines N 2,738 79,927

More information

Cardiothoracic Department October 9, Deborah Winters, RN BSN Clinical Excellence

Cardiothoracic Department October 9, Deborah Winters, RN BSN Clinical Excellence Cardiothoracic Department October 9, 2013 Deborah Winters, RN BSN Clinical Excellence Quarterly Executive Summary CathPCI Registry PCI Performance Measures PCI Process/Outcome Metrics Diagnostic Cath Process/Outcome

More information

Version 4.4. Institutional Outcomes Report 2014Q3. National Outcomes Report Aggregation Date: Jan 12, :59:59 PM

Version 4.4. Institutional Outcomes Report 2014Q3. National Outcomes Report Aggregation Date: Jan 12, :59:59 PM Version 4.4 Institutional Outcomes Report 2014Q3 National Outcomes Report 999997 Aggregation Date: Jan 12, 2015 11:59:59 PM Publish Date: Jan 29, 2015 If User desires to publish or otherwise distribute

More information

Dashboard and Outcomes Report with Case Studies

Dashboard and Outcomes Report with Case Studies Dashboard and Outcomes Report with Case Studies Kim Hustler Clinical Quality Consultant, American College of Cardiology The following relationships exist: Kim Hustler: No Disclosures Section F- Procedures

More information

2013, American Heart Association

2013, American Heart Association 2013, American Heart Association Mission: Lifeline - Data, Reports and ACTION Registry - GWTG THE MISSION: BETTER HEART ATTACK CARE FOR YOUR COMMUNITY THE LIFELINE: THE AMERICAN HEART ASSOCIATION AND YOU

More information

Mission: Lifeline Addressing the System of STEMI Care

Mission: Lifeline Addressing the System of STEMI Care Mission: Lifeline Addressing the System of STEMI Care Alice K. Jacobs, M.D. Boston University Medical Center Boston, MA, USA ACC West Virginia Chapter, April 2017 Disclosure Information FINANCIAL DISCLOSURE:

More information

CathPCI Registry Poster Abstract

CathPCI Registry Poster Abstract CathPCI Registry Poster Abstract Topic of Poster: Quality Improvement Initiative Title: Process Improvement to Meet Appropriate Use Criteria (AUC) for Elective Patients in the National Cardiovascular Data

More information

Comparing Effectively: The Role of Registries in Comparative Effectiveness Research

Comparing Effectively: The Role of Registries in Comparative Effectiveness Research Comparing Effectively: The Role of Registries in Comparative Effectiveness Research National Comparative Effectiveness Summit Washington DC September 16, 2009 Ralph Brindis, MD, MPH, FACC, FSCAI President-

More information

Recommendations for criteria for STEMI systems of care: A focus on pharmacoinvasive strategies

Recommendations for criteria for STEMI systems of care: A focus on pharmacoinvasive strategies Recommendations for criteria for STEMI systems of care: A focus on pharmacoinvasive strategies Mohammad Zubaid, MB, ChB, FRCPC, FACC Professor of Medicine, Kuwait University Chairman, Faculty of Cardiology,

More information

Data Elements and Definitions with Case Studies. Interpreting Your Outcomes Reports. Kim Hustler, Clinical Quality Consultant, NCDR

Data Elements and Definitions with Case Studies. Interpreting Your Outcomes Reports. Kim Hustler, Clinical Quality Consultant, NCDR Data Elements and Definitions with Case Studies Interpreting Your Outcomes Reports Kim Hustler, Clinical Quality Consultant, NCDR Beth Pruski, Program Manager, NCDR The following relationships exist: Beth

More information

Professional Society Roles in Drug-Device Cardiac Safety

Professional Society Roles in Drug-Device Cardiac Safety Professional Society Roles in Drug-Device Cardiac Safety TREATT II Thinktank Silver Spring, MD March 7, 2011 Ralph Brindis, MD MPH FACC President, American College of Cardiology Senior Advisor for CV Disease

More information

Ischemic Heart Disease Interventional Treatment

Ischemic Heart Disease Interventional Treatment Ischemic Heart Disease Interventional Treatment Cardiac Catheterization Laboratory Procedures (N = 89) is a regional and national referral center for percutaneous coronary intervention (PCI). A total of

More information

The Role of DHMC as an ST Elevation Myocardial Infarction Receiving Center in a Regional STEMI Care Network:

The Role of DHMC as an ST Elevation Myocardial Infarction Receiving Center in a Regional STEMI Care Network: The Role of DHMC as an ST Elevation Myocardial Infarction Receiving Center in a Regional STEMI Care Network: Nathaniel Niles, MD CREST Symposium November 7th, 28 STEMI = Acute Coronary Thrombosis STEMI

More information

Clinical Research State of the Art A View as a Clinical Trialist,, Registry Researcher, Educator, Physician

Clinical Research State of the Art A View as a Clinical Trialist,, Registry Researcher, Educator, Physician Clinical Research State of the Art A View as a Clinical Trialist,, Registry Researcher, Educator, Physician Christopher Cannon, MD TIMI Study Group, Cardiovascular Division, Brigham and Women s Hospital,

More information

Access Site Complications. Nick Cheshire MD FRCS, Professor of Vascular Surgery Imperial College Healthcare St Mary s Hospital Campus

Access Site Complications. Nick Cheshire MD FRCS, Professor of Vascular Surgery Imperial College Healthcare St Mary s Hospital Campus Access Site Complications Nick Cheshire MD FRCS, Professor of Vascular Surgery Imperial College Healthcare St Mary s Hospital Campus Surgeons & Cardiologists Interventional Cardiology 2008 Eye of a Hawk,

More information

Strokes After TAVR: Perspectives from the US CoreValve Trials

Strokes After TAVR: Perspectives from the US CoreValve Trials Strokes After TAVR: Perspectives from the US CoreValve Trials Jeffrey J. Popma, MD Professor of Medicine Harvard Medical School Director, Interventional Cardiology Clinical Services Beth Israel Deaconess

More information

Daily practice of ACS management in the Gulf: Data from Gulf COAST

Daily practice of ACS management in the Gulf: Data from Gulf COAST Daily practice of ACS management in the Gulf: Data from Gulf COAST Mohammad Zubaid, MB, ChB, FRCPC, FACC Professor of Medicine, Kuwait University Head, Division of Cardiology Mubarak Alkabeer Hospital

More information

2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non ST-Elevation Myocardial Infarction

2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non ST-Elevation Myocardial Infarction 2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non ST-Elevation Myocardial Infarction Ramzi Khalil MD FACC Assistant Professor Allegheny Gen.Hospital AHN Speakers

More information

STEMI Care 2014 at the Crossroads: Taking the right road

STEMI Care 2014 at the Crossroads: Taking the right road STEMI Care 2014 at the Crossroads: Taking the right road Robert C. Welsh, MD, FRCPC, FESC, FAHA, FACC Professor of Medicine Vice President, The Canadian Association of Interventional Cardiology Director,

More information

Know the Quality of our Care at Every Step. Kansas City ACS Summit BI-State Cardiovascular Education Consortium

Know the Quality of our Care at Every Step. Kansas City ACS Summit BI-State Cardiovascular Education Consortium Know the Quality of our Care at Every Step Kansas City ACS Summit BI-State Cardiovascular Education Consortium Welcome to the Kansas City ACS Summit Objectives: Follow the flow and care of an ACS patient

More information

Management of STEMI in era of Reperfusion. Eagles Peter Moyer, MD, MPH Medical Director Boston EMS, Fire and Police

Management of STEMI in era of Reperfusion. Eagles Peter Moyer, MD, MPH Medical Director Boston EMS, Fire and Police Management of STEMI in era of Reperfusion Eagles 2007 Peter Moyer, MD, MPH Medical Director Boston EMS, Fire and Police STEMI in US ST Segment Elevation Myocardial Infarction (STEMI) ~500 K per year Thrombolysis

More information

Institutional Outcomes Report 2012Q2 Sample Hospital

Institutional Outcomes Report 2012Q2 Sample Hospital Version 2.2 Institutional Outcomes Report 2012Q2 If User desires to publish or otherwise distribute or use, in whole or in part, any aggregate data or reports provided by ACCF, or produced in connection

More information

Joo-Yong Hahn, MD/PhD

Joo-Yong Hahn, MD/PhD Sungkyunkwan University School of Medicine Joo-Yong Hahn, MD/PhD Heart Vascular Stork Institute, Samsung Medical Center Sungkyunkwan University School of Medicine Grant support Korean Society of Interventional

More information

Ischemic Heart Disease Interventional Treatment

Ischemic Heart Disease Interventional Treatment Ischemic Heart Disease Interventional Treatment Cardiac Catheterization Laboratory Procedures (N = 11,61) is a regional and national referral center for percutaneous coronary intervention (PCI). A total

More information

Quality Improvement in the Cath Lab Today and Tomorrow. Sunil V. Rao MD The Duke Clinical Research Institute Duke University Medical Center

Quality Improvement in the Cath Lab Today and Tomorrow. Sunil V. Rao MD The Duke Clinical Research Institute Duke University Medical Center Quality Improvement in the Cath Lab Today and Tomorrow Sunil V. Rao MD The Duke Clinical Research Institute Duke University Medical Center Disclosures Consultant, Honoraria ZOLL, BMS, The Medicines Company,

More information

Patient and System Time Delay

Patient and System Time Delay Quality Indicators in the Management of ST-elevation Myocardial Infarction Patient and System Time Delay Jacob Thorsted Sorensen, MD, PhD Department of Cardiology Aarhus University Hospital, Denmark Disclosures

More information

TAB 7: SUB TAB: AMI/CHEST PAIN Specifications & Paper Tools

TAB 7: SUB TAB: AMI/CHEST PAIN Specifications & Paper Tools TAB 7: SUB TAB: AMI/CHEST PAIN Specifications & Paper Tools Material inside brackets ([and]) is new to this Specifications Manual version. Hospital Outpatient Quality Measures Acute Myocardial Infarction

More information

Get With The Guidelines: Lessons for National Healthcare Improvement Programs

Get With The Guidelines: Lessons for National Healthcare Improvement Programs Get With The Guidelines: Lessons for National Healthcare Improvement Programs Gregg C. Fonarow, MD, FACC, FAHA, FHFSA Eliot Corday Professor of Cardiovascular Medicine and Science UCLA Division of Cardiology

More information

Blue Distinction Centers for Cardiac Care 2018 Provider Survey

Blue Distinction Centers for Cardiac Care 2018 Provider Survey Blue Distinction Centers for Cardiac Care 2018 Provider Survey Printed version of this document is for reference purposes only. Paper copies of the Provider Survey and Team Table will not be accepted.

More information

Regional STEMI Transfer Systems: the Mayo and NC RACE Experiences

Regional STEMI Transfer Systems: the Mayo and NC RACE Experiences Regional STEMI Transfer Systems: the Mayo and NC RACE Experiences Dr. Henry H. Ting, Mayo Clinic College of Medicine Dr. James G. Jollis,, Duke University Medical Center Mayo Clinic STEMI System for Transferred

More information

Using STS/ACC TVT Registry Data for Quality Improvement (QI) Learning Objectives. Overview 3/12/2014

Using STS/ACC TVT Registry Data for Quality Improvement (QI) Learning Objectives. Overview 3/12/2014 Using STS/ACC TVT Registry Data for Quality Improvement (QI) March 27, 2014 Kim Marshall BSN, RN Quality Improvement Specialist We Improve Lives Learning Objectives Sources for data analysis for Transcatheter

More information

Treatment of ST-elevation myocardial infarction in China: Where are we?

Treatment of ST-elevation myocardial infarction in China: Where are we? Treatment of ST-elevation myocardial infarction in China: Where are we? Associate Professor, Yihong Sun, MD Peking University People s Hospital Beijing, China Disclosure conflict of Interest The Challenges

More information

Acute Coronary Syndromes

Acute Coronary Syndromes Overview Acute Coronary Syndromes Rabeea Aboufakher, MD, FACC, FSCAI Section Chief of Cardiology Altru Health System Grand Forks, ND Epidemiology Pathophysiology Clinical features and diagnosis STEMI management

More information

Transradial vs. Transfemoral Access in STEMI: Should We Randomize?

Transradial vs. Transfemoral Access in STEMI: Should We Randomize? Transradial vs. Transfemoral Access in STEMI: Should We Randomize? Ajay J. Kirtane, MD, SM Center for Interventional Vascular Therapy Columbia University Medical Center / New York Presbyterian Hospital

More information

ST Elevated Myocardial Infarction- Latest AHA recommendations

ST Elevated Myocardial Infarction- Latest AHA recommendations ST Elevated Myocardial Infarction- Latest AHA recommendations Sherry Turner, DO, MPH, FACOEP Medical Director Emergency Services Wesley Medical Center The Problem 250,000 Americans each year 30% fail to

More information

Controversies on Primary angioplasty in STEMI

Controversies on Primary angioplasty in STEMI Controversies on Primary angioplasty in STEMI 원주의대이승환 Case ( 51/M) CC C.C: ongoing squeezing chest pain D : for 2 hours Risk factors Current smoker ( 40 PYs) Hypercholesterolemia (+) Case ( 51/M) Physical

More information

Cardiogenic Shock and Initiatives to Reduce Mortality

Cardiogenic Shock and Initiatives to Reduce Mortality Cardiogenic Shock and Initiatives to Reduce Mortality Tanveer Rab, MD, FACC William O Neill, MD, FACC Perwaiz Meraj, MD, FACC Alex Truesdell, MD, FACC The Golden Hours? 50% dead within 10 hours Overall

More information

REFERRAL HOSPITAL. The Importance of Door In Door Out Time DIDO

REFERRAL HOSPITAL. The Importance of Door In Door Out Time DIDO REFERRAL HOSPITAL The Importance of Door In Door Out Time DIDO Jean Skonhovd,RN,BSN,MSAS Emergency Department Director Avera Heart Hospital of South Dakota Time to Treatment is critical for STEMI patients

More information

William D. Salerno, M.D. Director, Coronary Care Unit Hackensack University Medical Center Clinical Associate Professor of Medicine, UMDNJ

William D. Salerno, M.D. Director, Coronary Care Unit Hackensack University Medical Center Clinical Associate Professor of Medicine, UMDNJ William D. Salerno, M.D. Director, Coronary Care Unit Hackensack University Medical Center Clinical Associate Professor of Medicine, UMDNJ PROBLEM: blood supply to the heart has been compromised and heart

More information

Physician Self-referral and Health Care Utilization. Rita F. Redberg, MD, MSc Professor of Medicine UCSF Medical Center

Physician Self-referral and Health Care Utilization. Rita F. Redberg, MD, MSc Professor of Medicine UCSF Medical Center Physician Self-referral and Health Care Utilization Rita F. Redberg, MD, MSc Professor of Medicine UCSF Medical Center Physician self-referral why should we care? Extent of occurrences Impact of physician

More information

Published Manuscripts Based in the STS/ACC TVT Registry

Published Manuscripts Based in the STS/ACC TVT Registry Published Manuscripts Based in the STS/ACC TVT Registry June 2018 Legend Manuscript Status is designated as follows: Abbreviations: Published/Full Citation Provided: Manuscript is in print. In Press: Manuscript

More information

Eagles 2007 Focused Quality in EMS The Five Required Actions

Eagles 2007 Focused Quality in EMS The Five Required Actions Eagles 2007 Focused Quality in EMS The Five Required Actions Corey M. Slovis, M.D. Vanderbilt University Medical Center Metro Nashville Fire Department Nashville International Airport Nashville, TN Prior

More information

Clinical Lessons from BMC2-PCI

Clinical Lessons from BMC2-PCI Clinical Lessons from BMC2-PCI The Blue Cross Blue Shield of Michigan Cardiovascular Consortium Hitinder Gurm, M.D. University of Michigan Overview 32 papers since inception 10 papers published this year

More information

Data Requirements. Accreditation for Cardiovascular Excellence Quality in Invasive Cardiovascular Care

Data Requirements. Accreditation for Cardiovascular Excellence Quality in Invasive Cardiovascular Care 2011 Data Requirements Accreditation for Cardiovascular Excellence Quality in Invasive Cardiovascular Care 2400 N Street NW, Suite 500 Washington, D.C. 20037-1153 T: 202-657-6859 1 1. 2. It is required

More information

CARDIOLOGY. State of the state. news you can use. upcoming events. in Colorado. John C. Messenger, MD, FACC PAGE 7-8

CARDIOLOGY. State of the state. news you can use. upcoming events. in Colorado. John C. Messenger, MD, FACC PAGE 7-8 CARDIOLOGY in Colorado Winter 2017 www.coloradoacc.org State of the state John C. Messenger, MD, FACC PAGE 7-8 news you can use Tools that are available to you to use from JACC.org PAGE 3-6 upcoming events

More information

Use of Registry Data for Post Market Device Surveillance: IOM Presentation

Use of Registry Data for Post Market Device Surveillance: IOM Presentation Use of Registry Data for Post Market Device Surveillance: IOM Presentation Eric D. Peterson, MD, MPH Professor of Medicine Vice Chair of Quality, Dept of Medicine Director of CV Research Duke Clinical

More information

The Window for Fibrinolysis. Frans Van de Werf, MD, PhD Leuven, Belgium

The Window for Fibrinolysis. Frans Van de Werf, MD, PhD Leuven, Belgium The Window for Fibrinolysis Frans Van de Werf, MD, PhD Leuven, Belgium ESC STEMI Guidelines : December 2008 Reperfusion Therapy: Fibrinolytic Therapy Recommendations Class LOE In the absence of contraindications

More information

Published Manuscripts Based in the STS/ACC TVT Registry

Published Manuscripts Based in the STS/ACC TVT Registry Published Manuscripts Based in the STS/ACC TVT Registry June 2018 Legend Manuscript Status is designated as follows: Abbreviations: Published/Full Citation Provided: Manuscript is in print. In Press: Manuscript

More information

From STEMIs to Stents: Updates in PCI practice

From STEMIs to Stents: Updates in PCI practice From STEMIs to Stents: Updates in PCI practice Arnold Seto, MD, MPA Assistant Clinical Professor, UC-Irvine and Long Beach VA Director of Interventional Cardiology Research Hospitalizations in the U.S.

More information

News the. Methods Data collection. The NCDR is a national registry of patients undergoing diagnostic cardiac catheterizations

News the. Methods Data collection. The NCDR is a national registry of patients undergoing diagnostic cardiac catheterizations Journal of the American College of Cardiology Vol. 52, No. 20, 2008 2008 by the American College of Cardiology Foundation ISSN 0735-1097/08/$34.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2008.08.017

More information

National Efforts to Improve Door-to-Balloon Time

National Efforts to Improve Door-to-Balloon Time Journal of the American College of Cardiology Vol. 54, No. 25, 2009 2009 by the American College of Cardiology Foundation ISSN 0735-1097/09/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2009.11.003

More information

CARDIOLOGY GRAND ROUNDS

CARDIOLOGY GRAND ROUNDS CARDIOLOGY GRAND ROUNDS Presentation: Mitral Disease Speakers: Robert S. Farivar, MD, PhD Chief, Cardiothoracic Surgery, Abbott Northwestern Hospital Chairman, Allina Cardiothoracic; Minneapolis Heart

More information

STEMI, Non-STEMI, Chest Pain?

STEMI, Non-STEMI, Chest Pain? Minnesota Chest Pain / Acute Coronary Syndrome Tool-Kit Patient with Chest Pain Or Potential Acute Coronary Syndrome STEMI, n-stemi, Chest Pain? Follow MN STEMI Guideline Follow MN n-stemi Guideline Follow

More information

Antithrombotic Therapy in ACS Pretreatment in STEMI. Christian W. Hamm Kerckhoff Heart & Thorax Center Bad Nauheim Germany

Antithrombotic Therapy in ACS Pretreatment in STEMI. Christian W. Hamm Kerckhoff Heart & Thorax Center Bad Nauheim Germany Antithrombotic Therapy in ACS Pretreatment in STEMI Christian W. Hamm Kerckhoff Heart & Thorax Center Bad Nauheim Germany Potential conflicts of interest Speaker s name: Christian W. Hamm I have the following

More information

Platelet function testing to guide P2Y 12 -inhibitor treatment in ACS patients after PCI: insights from a national program in Hungary

Platelet function testing to guide P2Y 12 -inhibitor treatment in ACS patients after PCI: insights from a national program in Hungary Platelet function testing to guide P2Y 12 -inhibitor treatment in ACS patients after PCI: insights from a national program in Hungary Dániel Aradi MD PhD Interventional Cardiologist Assistant professor

More information

NHS QIS National Measurement of Audit Acute Coronary Syndrome

NHS QIS National Measurement of Audit Acute Coronary Syndrome NHS QIS National Measurement of Audit Acute Coronary Syndrome Things have changed based on the experience and feedback from the first cycle of measurement and, for the better we think! The Acute Coronary

More information

Conflits d intérêt Astra-Zeneca, BMS, MSD, Novartis, Pfizer, Daiichi-Sankyo, Servier, CRAM, AFSSAPS, ARH Région de Bourgogne Clos Vougeot

Conflits d intérêt Astra-Zeneca, BMS, MSD, Novartis, Pfizer, Daiichi-Sankyo, Servier, CRAM, AFSSAPS, ARH Région de Bourgogne Clos Vougeot Conflits d intérêt Astra-Zeneca, BMS, MSD, Novartis, Pfizer, Daiichi-Sankyo, Servier, CRAM, AFSSAPS, ARH Région de Bourgogne Clos Vougeot Agrément FMC N 100 437 Popul. millions Area km2 Density inha/km2

More information

Cardiology Department. Clinical Governance

Cardiology Department. Clinical Governance Cardiology Department Clinical Governance Background Cardiology department has a high throughput of emergency and elective patients Two acute sites CAH and DHH Cardiac investigation department provides

More information

HF and CRT: CRT-P versus CRT-D

HF and CRT: CRT-P versus CRT-D HF and CRT: CRT-P versus CRT-D Andrew E. Epstein, MD Professor of Medicine, Cardiovascular Division University of Pennsylvania Chief, Cardiology Section Philadelphia VA Medical Center Philadelphia, PA

More information

Αντιαιμοπεταλιακη αγωγη (ποια, πο τε και για πο σο)

Αντιαιμοπεταλιακη αγωγη (ποια, πο τε και για πο σο) Αντιαιμοπεταλιακη αγωγη (ποια, πο τε και για πο σο) Dimitrios Alexopoulos, MD, FESC, FACC Cardiology Department, Patras University Hospital, Patras, Rio, Greece. Patras University Hospital I, Dimitrios

More information

Is it Time for a National Network of Valve Centers? MICHAEL MACK, MD BAYLOR SCOTT & WHITE HEALTH

Is it Time for a National Network of Valve Centers? MICHAEL MACK, MD BAYLOR SCOTT & WHITE HEALTH Is it Time for a National Network of Valve Centers? MICHAEL MACK, MD BAYLOR SCOTT & WHITE HEALTH 10 Potential Conflict of Interest Disclosure Board of Trustees American College of Cardiology Writing Committee

More information

Marcin Dada, MD December 03, 2013

Marcin Dada, MD December 03, 2013 STEMI Imposters Marcin Dada, MD December 03, 2013 Marcin Dada, MD Associate Director, Chest Pain Center Hartford Hospital, Hartford, CT Member, AHA Mission Lifeline Steering Committee Outline of Topics

More information

Verwendung von routinemässig erhobenen Daten für pragmatische randomisierte Studien: Erste Erfahrungen in der Schweiz

Verwendung von routinemässig erhobenen Daten für pragmatische randomisierte Studien: Erste Erfahrungen in der Schweiz Verwendung von routinemässig erhobenen Daten für pragmatische randomisierte Studien: Erste Erfahrungen in der Schweiz Landesmuseum, Zürich, 21. November 2017 Prof. Dr. med. Heiner C. Bucher MPH Institut

More information

Igor Palacios, MD Director of Interventional Cardiology Massachusetts General Hospital Professor of Medicine Harvard Medical School

Igor Palacios, MD Director of Interventional Cardiology Massachusetts General Hospital Professor of Medicine Harvard Medical School Aortic Stenosis: Current State of Percutaneous Therapies, Emerging Technologies and Future Directions Igor Palacios, MD Director of Interventional Cardiology Massachusetts General Hospital Professor of

More information

Q1 Contact Information

Q1 Contact Information Q1 Contact Information Answered: 25 Skipped: 0 ANSWER CHOICES Hospital Name of Person Completing Survey Email RESPONSES 100.00% 25 100.00% 25 100.00% 25 # HOSPITAL DATE 1 Research Medical Center 9/26/2018

More information

Is it worth offering cardiovascular disease prevention to the elderly? Prof. Dr. Helmut Gohlke Herz-Zentrum Bad Krozingen, Germany

Is it worth offering cardiovascular disease prevention to the elderly? Prof. Dr. Helmut Gohlke Herz-Zentrum Bad Krozingen, Germany Is it worth offering cardiovascular disease prevention to the elderly? Prof. Dr. Helmut Gohlke Herz-Zentrum Bad Krozingen, Germany Is it worth offering cardiovascular disease prevention to the elderly?

More information

Patient Transfer. Mark de Belder The James Cook University Hospital Middlesbrough

Patient Transfer. Mark de Belder The James Cook University Hospital Middlesbrough Patient Transfer Mark de Belder The James Cook University Hospital Middlesbrough Current Management Strategies for ACS ACS No ST Elevation ST ST Elevation Elevation Early Invasive Early Conservative Fibrinolysis

More information

How Long Patietns Will Be on Dual Antiplatelet Therapy?

How Long Patietns Will Be on Dual Antiplatelet Therapy? How Long Patietns Will Be on Dual Antiplatelet Therapy? Ron Waksman,, MD, FACC Professor of Medicine (Cardiology) Georgetown University Associate Director, Division of Cardiology, Washington Hospital Center

More information

Cardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides

Cardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides Cardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides Colette Seifer MB(Hons) FRCP(UK) Associate Professor, University of Manitoba, Cardiologist, Cardiac Sciences Program, St Boniface Hospital

More information

Lead Author Abstract Title Type:

Lead Author Abstract Title Type: AHA SS / ReSS 2017 Anaheim, CA Nov 11-15, 2017 Accepted Abstracts - 22 Total Lead Author Abstract Title Type: GWTG-National Abstracts (6) Leslie L Chang, Duke Univ, Durham, NC (AHA Young S3274 / 3274 -

More information

Decision for fibrinolysis or primary PCI in the prehospital phase

Decision for fibrinolysis or primary PCI in the prehospital phase Decision for fibrinolysis or primary PCI in the prehospital phase Nicolas Danchin, Hôpital Européen Georges Pompidou, Paris, France Disclosures Research grants: Astrazeneca, Eli-Lilly, GSK, Merck, Novartis,

More information

NEBRASKA STEMI CONFERENCE 2015 Dr. Doug Kosmicki. 2013, American Heart Association

NEBRASKA STEMI CONFERENCE 2015 Dr. Doug Kosmicki. 2013, American Heart Association NEBRASKA STEMI CONFERENCE 2015 Dr. Doug Kosmicki 2013, American Heart Association 1 Dr. Doug Kosmicki Reperfusion Strategies Disclosure Information Report any disclosure information of conflicts of interest.

More information

Appropriateness of Percutaneous Coronary Interventions in Washington State

Appropriateness of Percutaneous Coronary Interventions in Washington State Appropriateness of Percutaneous Coronary Interventions in Washington State Steven M. Bradley, Charles Maynard, Chris L. Bryson VA Puget Sound Healthcare System and University of Washington Presenter Disclosure

More information

Outcomes in the Commercial Use of Self-expanding Prostheses in Transcatheter Aortic Valve Replacement: A Comparison of the Medtronic CoreValve and

Outcomes in the Commercial Use of Self-expanding Prostheses in Transcatheter Aortic Valve Replacement: A Comparison of the Medtronic CoreValve and Outcomes in the Commercial Use of Self-expanding Prostheses in Transcatheter Aortic Valve Replacement: A Comparison of the Medtronic CoreValve and Evolut R platforms in the Society of Thoracic Surgeons/American

More information

Pharmaco-Invasive Approach for STEMI

Pharmaco-Invasive Approach for STEMI Pharmaco-Invasive Approach for STEMI Michael C. Kontos, MD Medical Director, Coronary Intensive Care Unit Director, Chest Pain Evaluation Center Associate Professor Departments of Internal Medicine (Cardiology),

More information

Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary PCI

Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary PCI Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary PCI Dr Sasha Koul, MD Dept of Cardiology, Lund University Hospital, Lund, Sweden

More information

ST- Segment Elevation Myocardial Infarction Challenges in Diagnosis & Current Measures of Quality

ST- Segment Elevation Myocardial Infarction Challenges in Diagnosis & Current Measures of Quality ST- Segment Elevation Myocardial Infarction Challenges in Diagnosis & Current Measures of Quality James M. McCabe, MD, FACC, FAHA Cath Lab Director, University of Washington Disclosures I, James McCabe,

More information

Simon A. Mahler MD, MS, FACEP Associate Professor Department of Emergency Medicine Wake Forest School of Medicine

Simon A. Mahler MD, MS, FACEP Associate Professor Department of Emergency Medicine Wake Forest School of Medicine Simon A. Mahler MD, MS, FACEP Associate Professor Department of Emergency Medicine Wake Forest School of Medicine Research funding: American Heart Association Donaghue Foundation/ Association of American

More information

Preventing Sudden Death Current & Future Role of ICD Therapy

Preventing Sudden Death Current & Future Role of ICD Therapy Preventing Sudden Death Current & Future Role of ICD Therapy Derek V Exner, MD, MPH, FRCPC, FACC, FAHA, FHRS Professor, Libin Cardiovascular Institute of Alberta Canada Research Chair, Cardiovascular Clinical

More information

Intro to Science & Quality. Prepared for Emerging Faculty September 2014 Julia Chang, VP Science & Quality

Intro to Science & Quality. Prepared for Emerging Faculty September 2014 Julia Chang, VP Science & Quality Intro to Science & Quality Prepared for Emerging Faculty September 2014 Julia Chang, VP Science & Quality jchang@acc.org Science & Quality A division within the College ACC Science & Quality Education

More information

Utilization and Impact of Pre-Hospital Electrocardiograms for Patients With Acute ST-Segment Elevation Myocardial Infarction

Utilization and Impact of Pre-Hospital Electrocardiograms for Patients With Acute ST-Segment Elevation Myocardial Infarction Journal of the American College of Cardiology Vol. 53, No. 2, 2009 2009 by the American College of Cardiology Foundation ISSN 0735-1097/09/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2008.09.030

More information

A bs tr ac t. n engl j med 369;10 nejm.org september 5,

A bs tr ac t. n engl j med 369;10 nejm.org september 5, The new england journal of medicine established in 1812 september 5, 213 vol. 369 no. 1 Door-to-Balloon Time and Mortality among Patients Undergoing Primary PCI Daniel S. Menees, M.D., Eric D. Peterson,

More information

Radial Artery Access Improving Outcomes and Decreasing Costs

Radial Artery Access Improving Outcomes and Decreasing Costs Howard A. Cohen, MD, FACC, FSCAI Director, Division of Cardiac Intervention Co-Director, Cardiac Catheterization Laboratories Lenox Hill Heart & Vascular Institute Institute DISCLOSURE Nothing to disclose

More information

A Large Prospective Randomized Trial of DES vs BMS in Patients with STEMI

A Large Prospective Randomized Trial of DES vs BMS in Patients with STEMI HORIZONS-AMI: A Large Prospective Randomized Trial of DES vs BMS in Patients with STEMI Gregg W. Stone MD Columbia University Medical Center Cardiovascular Research Foundation Disclosures Gregg W. Stone

More information

PCI Guidelines: Essentials for Understanding the Appropriate Use Criteria. J. Jeffrey Marshall, MD, FSCAI

PCI Guidelines: Essentials for Understanding the Appropriate Use Criteria. J. Jeffrey Marshall, MD, FSCAI PCI Guidelines: Essentials for Understanding the Appropriate Use Criteria J. Jeffrey Marshall, MD, FSCAI December 8, 2013 Disclosures None PCI Guidelines: Essentials for Understanding the Appropriate

More information

What are the most common clinical scenarios that cause a PCI case to be deemed INAPPROPRIATE by AUC?

What are the most common clinical scenarios that cause a PCI case to be deemed INAPPROPRIATE by AUC? What are the most common clinical scenarios that cause a PCI case to be deemed INAPPROPRIATE by AUC? Michael A. Kutcher, MD, FSCAI Henry S. Jennings, III, MD, FSCAI The SCAI-Quality Improvement Toolkit

More information

Xi Li, Jing Li, Frederick A Masoudi, John A Spertus, Zhenqiu Lin, Harlan M Krumholz, Lixin Jiang for the China PEACE Collaborative Group

Xi Li, Jing Li, Frederick A Masoudi, John A Spertus, Zhenqiu Lin, Harlan M Krumholz, Lixin Jiang for the China PEACE Collaborative Group China PEACE risk estimation tool for inhospital death from acute myocardial infarction: an early risk classification tree for decisions about fibrinolytic therapy Xi Li, Jing Li, Frederick A Masoudi, John

More information

Sanford Chest Pain Network: Improving Rural STEMI Outcomes

Sanford Chest Pain Network: Improving Rural STEMI Outcomes Sanford Chest Pain Network: Improving Rural STEMI Outcomes Naveen Rajpurohit, MD Cardiovascular Fellow Sanford Cardiovascular Institute Sanford Heart Hospital The University of South Dakota Sioux Falls,

More information

ACCP Cardiology PRN Journal Club

ACCP Cardiology PRN Journal Club ACCP Cardiology PRN Journal Club 1 Optimising Crossover from Ticagrelor to Clopidogrel in Patients with Acute Coronary Syndrome [CAPITAL OPTI-CROSS] Monique Conway, PharmD, BCPS PGY-2 Cardiology Pharmacy

More information

Cardiologists and HbA1c: Novel Diabetes Drugs and Cardiovascular Disease Outcomes

Cardiologists and HbA1c: Novel Diabetes Drugs and Cardiovascular Disease Outcomes Biomarkers 2018 Cardiologists and HbA1c: Novel Diabetes Drugs and Cardiovascular Disease Outcomes Gregg C. Fonarow, MD, FACC, FAHA, FHFSA Elliot Corday Professor of Cardiovascular Medicine UCLA Division

More information

Acute Coronary Syndrome (ACS) is the consequence of

Acute Coronary Syndrome (ACS) is the consequence of Clinical Practice Pharmaco-invasive Therapy for STEMI; The Most Suitable STEMI Reperfusion Therapy for Transferred Patients in Thailand Pradub Sukhum, MD. 1 1 Division of Cardiovascular Medicine, Bangkok

More information

STEMI in the State of Jefferson ASSET - 5 Years Later. Brian W. Gross, MD, FACC Mary Barnum, RN, BSN Karen Bales, RN, BSN Rogue Valley Medical Center

STEMI in the State of Jefferson ASSET - 5 Years Later. Brian W. Gross, MD, FACC Mary Barnum, RN, BSN Karen Bales, RN, BSN Rogue Valley Medical Center STEMI in the State of Jefferson ASSET - 5 Years Later Brian W. Gross, MD, FACC Mary Barnum, RN, BSN Karen Bales, RN, BSN Rogue Valley Medical Center Sept 22, 2008 Percent # Procedures Performed Coronary

More information

Mark C. Bieniarz, MD Andrew Harrell, MD Peter Berger, MD

Mark C. Bieniarz, MD Andrew Harrell, MD Peter Berger, MD Mark C. Bieniarz, MD Andrew Harrell, MD Peter Berger, MD Should PCI center activate the cathlab off EMS field interpretation of ECG? Is this happening consistently in New Mexico? What is acceptable rate

More information

Efforts to Improve Outcomes of In-Hospital Cardiac Arrest in the VA

Efforts to Improve Outcomes of In-Hospital Cardiac Arrest in the VA Efforts to Improve Outcomes of In-Hospital Cardiac Arrest in the VA Steven M. Bradley, MD, MPH VA Eastern Colorado Health Care System, Denver, CO University of Colorado School of Medicine, Aurora, CO Disclaimer

More information

Coronary Catheterization and Percutaneous Coronary Intervention in China 10-Year Results From the China PEACE-Retrospective CathPCI Study

Coronary Catheterization and Percutaneous Coronary Intervention in China 10-Year Results From the China PEACE-Retrospective CathPCI Study Coronary Catheterization and Percutaneous Coronary Intervention in China 10-Year Results From the China PEACE-Retrospective CathPCI Study Xin Zheng, MD, PhD; Jeptha P. Curtis, MD; Shuang Hu, PhD; YongfeiWang,

More information

The Strategic Reperfusion Early After STEMI study Implications for clinical practice

The Strategic Reperfusion Early After STEMI study Implications for clinical practice The Strategic Reperfusion Early After STEMI study Implications for clinical practice Robert C. Welsh, MD, FRCPC Associate Professor of Medicine Director, Adult Cardiac Catheterization and Interventional

More information

TAVR: Review of the Robust Data from Randomized Trials

TAVR: Review of the Robust Data from Randomized Trials TAVR: Review of the Robust Data from Randomized Trials Nicholas J. Ruggiero II, MD,FACP, FACC, FSCAI, FSVM, FCPP Director, Structural Heart Disease and Non-Coronary Interventions Director, Jefferson Heart

More information